The EULAR 2026 conference in London, UK, has unveiled a range of strategies aimed at enhancing the quality of life for patients with rheumatic and musculoskeletal diseases (RMDs). These initiatives address critical areas such as fatigue, caregiver experiences, diagnostic delays, and the cost-effectiveness of patient education. Here's a deep dive into these developments and their implications.
Combating Fatigue with Integrated Approaches
One of the most intriguing findings presented at EULAR 2026 is the successful implementation of the COMbined Fatigue Intervention (COMFI) in Denmark and Sweden. COMFI combines tailored physical activity and cognitive behavioral approaches, two well-known strategies for managing fatigue in inflammatory arthritis. The study, led by Astrid Damgaard, involved 29 patients and demonstrated a promising reduction in fatigue levels after six months. The results showed a tendency towards reduced fatigue, with changes meeting the minimal clinically important difference in all fatigue measurements, including severity, impact, and coping subscales.
This approach's success lies in its integration of physical and cognitive strategies, offering a comprehensive solution to a common and burdensome symptom. The study's findings suggest that combining these approaches could significantly improve the lives of patients with inflammatory arthritis, providing a more holistic approach to managing fatigue.
Addressing Caregiver Challenges
RMD management often relies on the support of caregivers, yet the lived experiences of these individuals have been largely overlooked. Rikke Helene Moe, Vice-President of Health Professionals in Rheumatology at EULAR, highlighted this gap in research. An Italian phenomenological study presented at EULAR revealed the emotional distress, helplessness, and guilt that caregivers often face. The study, which interviewed 25 caregivers, mostly spouses and partners, underscored the need for caregiver-focused assessments and interventions.
By recognizing and addressing the challenges faced by caregivers, healthcare systems can improve patient outcomes and provide more holistic, person-centered care. This shift in focus towards caregivers is essential for ensuring that the support network of patients with RMDs is adequately supported, ultimately leading to better overall health outcomes.
Reducing Diagnostic Delays
Diagnostic delays are a significant obstacle for patients with RMDs, particularly those with axial spondyloarthritis (axSpA). The global mean delay to diagnosis for axSpA is a staggering 7.4 years, as noted in the EULAR 2026 presentations. A Canadian study, the FASTRAX trial, introduced an interdisciplinary model to improve access to rheumatology care and promote early identification.
The FASTRAX study, led by Laura Passalent, utilizes trained extended scope providers and rheumatology fellows to quickly screen patients with chronic low back pain. With a median wait time to assessment of just 28 days, the model has already shown success. Of the 179 patients screened, 22.9% were diagnosed with axSpA, with a mean time to diagnosis of 12.1 years.
The study's findings suggest that this approach can significantly reduce diagnostic delays, allowing for earlier intervention and improved patient outcomes. As the model gains awareness and matures, the time to diagnosis is expected to decrease further, emphasizing the importance of early screening and access to rheumatology care.
Conclusion: A Holistic Approach to Patient Care
The EULAR 2026 conference has shed light on several critical aspects of patient care in rheumatology. From fatigue management to caregiver support and diagnostic delays, these strategies offer a more holistic approach to improving the quality of life for patients with RMDs. By addressing these diverse challenges, healthcare professionals can provide more comprehensive and effective care, ultimately leading to better patient outcomes and a higher quality of life for those living with RMDs.
